| Health Care Technology Industry | Healthcare Sector | - CEO | TASE Exchange | IL0002780109 ISIN |
| Israel Country | - Employees | 13 Nov 2014 Last Dividend | 30 Oct 2016 Last Split | - IPO Date |
Wilk Technologies Ltd is an innovative enterprise with a focal point on the research and development of cultured milk, operating from its foundation in Rehovot, Israel. Initially established in 1986, the company embarked on its journey under the name Biomilk Ltd. before transitioning to its current identity in November 2021. Through its pioneering research endeavors, Wilk Technologies Ltd aims to redefine dairy production methodologies by focusing on cell-based solutions that promise sustainability and efficiency.
At the core of Wilk Technologies Ltd's portfolio lies its cultured milk products, developed through cutting-edge scientific research. These offerings represent a significant advancement in dairy production, embracing cellular agriculture to create milk without the necessity for traditional animal farming practices. This approach not only seeks to address environmental concerns associated with conventional dairy farming but also aims to provide consumers with sustainable and ethical dairy alternatives.